Rifaximin

Records for this ingredient, by country (identity only).

ATC A07AA11 · 11 markets · 90 records

Rifaximin 11 markets · 90 records Forms
Filters

CN 52 records · 7 shown of 7 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 200 mgtablet及利晴利福昔明昔服申、欧克双、Manufacturer: 南昌市飞弘药业有限公司、Manufacturer: 苏州二叶制药有限公司、Manufacturer: 重庆赛诺生物药业股份有限公司 also in GB·US·AU
    +3Other 3 marketsESMXJP
  • 100 mgcapsule希捷利福昔明弗皆亭、Manufacturer: 浙江安宝药业有限公司、Manufacturer: 海南全星制药有限公司
  • 200 mgcapsule紫军利福昔明Manufacturer: 上海新亚药业闵行有限公司、Manufacturer: 浙江安宝药业有限公司
  • 100 mgtablet欧克双利福昔明Manufacturer: 山东淄博新达制药有限公司
  • 200 mg per mL / per unit basis not statedliquidManufacturer: 山东达因海洋生物制药股份有限公司 ×14Manufacturer: 扬州市三药制药有限公司
  • 100 mg per mL / per unit basis not statedliquid威利宁利福昔明Manufacturer: 山东达因海洋生物制药股份有限公司
  • 200 mgpowderManufacturer: 上海新亚药业闵行有限公司 ×3

GB 13 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

  • 200 mgtabletNormix 200mg tabletsXifaxanta 200mg tablets、Manufacturer: Special Order also in CN·US·AU
    +3Other 3 marketsESMXJP
  • 550 mgtabletTargaxan 550mg tabletsXIFAXAN、Manufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Norgine Pharmaceuticals Ltd、Manufacturer: Special Order also in US·AU·ES
    +3Other 3 marketsCASGFR
  • 100 mg/5 mLliquidNormix 100mg/5ml granules for oral suspensionManufacturer: Special Order

US 4 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

AU 4 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 200 mgtabletXIFAXAN rifaximin 550 mg tablet blister pack also in CN·GB·US
    +3Other 3 marketsESMXJP
    unknown
  • 550 mgtabletXIFAXANXIFAXAN rifaximin 550 mg tablet blister pack also in GB·US·ES
    +3Other 3 marketsCASGFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 3 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

MX 3 records · 1 shown of 1 Source COFEPRIS · Data as of annual

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 550 mgtabletLUPIN-RIFAXIMINZAXINE also in GB·US·AU
    +3Other 3 marketsESSGFR

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名REFERO TABLETS 550MG ×1XIFAXAN ×5

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 200 mgtabletリフキシマ錠200mg also in CN·GB·US
    +3Other 3 marketsAUESMX

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 550 mgtabletTIXTAR 550 mg, comprimé pelliculé also in GB·US·AU
    +3Other 3 marketsESCASG

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.